Clinical trial
Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor…
NCT00101426 · Sumitomo Pharma Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00101426 |
|---|---|
| Title | Safety and Efficacy of AS-3201 in the Treatment of Diabetic Sensorimotor Polyneuropathy |
| Lead sponsor | Sumitomo Pharma Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetic Neuropathy |
| Intervention type | Drug |
| Interventions | ranirestat, (AS-3201) |
| Enrollment | 500 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Jan 11, 2005 |
| Last update posted | Jan 14, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: